Study: NCT00758264

Adverse event: Pneumonia
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 182 at risk

Adverse event: Croup infectious
Serious: yes
Organ System: Infections and infestations
Frequency: 2 affected / 182 at risk

Adverse event: Bronchiolitis
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 182 at risk

Adverse event: Febrile convulsion
Serious: yes
Organ System: Nervous system disorders
Frequency: 1 affected / 182 at risk

Adverse event: Gastroenteritis bacterial
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 182 at risk

Adverse event: Ileus paralytic
Serious: yes
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 182 at risk

Adverse event: Childhood asthma
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 182 at risk

Adverse event: Pharyngitis
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 182 at risk

Adverse event: Respiratory tract infection
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 182 at risk

Adverse event: Nasopharyngitis (post-Dose 1)
Serious: no
Organ System: Infections and infestations
Frequency: 25 affected / 182 at risk

Adverse event: Upper respiratory tract infection (post-Dose 1)
Serious: no
Organ System: Infections and infestations
Frequency: 22 affected / 182 at risk

Adverse event: Pain (post-Dose 1 of Synflorix)
Serious: no
Organ System: General disorders
Frequency: 90 affected / 180 at risk

Adverse event: Pain (post-Dose 1 of Nimenrix)
Serious: no
Organ System: General disorders
Frequency: 87 affected / 180 at risk

Adverse event: Redness (post-Dose 1 of Synflorix)
Serious: no
Organ System: General disorders
Frequency: 54 affected / 180 at risk

Adverse event: Redness (post-Dose 1 of Nimenrix)
Serious: no
Organ System: General disorders
Frequency: 56 affected / 180 at risk

Adverse event: Swelling (post-Dose 1 of Synflorix)
Serious: no
Organ System: General disorders
Frequency: 70 affected / 180 at risk

Adverse event: Swelling (post-Dose 1 of Nimenrix)
Serious: no
Organ System: General disorders
Frequency: 66 affected / 180 at risk

Adverse event: Drowsiness (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 59 affected / 180 at risk

Adverse event: Irritability (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 72 affected / 180 at risk

Adverse event: Loss of appetite (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 55 affected / 180 at risk

Adverse event: Temperature (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 25 affected / 180 at risk

Adverse event: Pneumonia
Serious: yes
Organ System: Infections and infestations
Frequency: 2 affected / 91 at risk

Adverse event: Head injury
Serious: yes
Organ System: Injury, poisoning and procedural complications
Frequency: 1 affected / 91 at risk

Adverse event: Otitis media acute
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 91 at risk

Adverse event: Nasopharyngitis (post-Dose 1)
Serious: no
Organ System: Infections and infestations
Frequency: 15 affected / 91 at risk

Adverse event: Upper respiratory tract infection (post-Dose 1)
Serious: no
Organ System: Infections and infestations
Frequency: 6 affected / 91 at risk

Adverse event: Nasopharyngitis (post-Dose 2)
Serious: no
Organ System: Infections and infestations
Frequency: 14 affected / 91 at risk

Adverse event: Upper respiratory tract infection (post-Dose 2)
Serious: no
Organ System: Infections and infestations
Frequency: 6 affected / 91 at risk

Adverse event: Upper respiratory tract infection bacterial (post-Dose 2)
Serious: no
Organ System: Infections and infestations
Frequency: 2 affected / 91 at risk

Adverse event: Pain (post-Dose 1 of Nimenrix)
Serious: no
Organ System: General disorders
Frequency: 40 affected / 91 at risk

Adverse event: Redness (post-Dose 1 of Nimenrix)
Serious: no
Organ System: General disorders
Frequency: 31 affected / 91 at risk

Adverse event: Swelling (post-Dose 1 of Nimenrix)
Serious: no
Organ System: General disorders
Frequency: 37 affected / 91 at risk

Adverse event: Pain (post-Dose 2 of Synflorix)
Serious: no
Organ System: General disorders
Frequency: 43 affected / 91 at risk

Adverse event: Redness (post-Dose 2 of Synflorix)
Serious: no
Organ System: General disorders
Frequency: 29 affected / 91 at risk

Adverse event: Swelling (post-Dose 2 of Synflorix)
Serious: no
Organ System: General disorders
Frequency: 38 affected / 91 at risk

Adverse event: Drowsiness (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 21 affected / 91 at risk

Adverse event: Irritability (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 33 affected / 91 at risk

Adverse event: Loss of appetite (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 22 affected / 91 at risk

Adverse event: Temperature (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 10 affected / 91 at risk

Adverse event: Drowsiness (post-Dose 2)
Serious: no
Organ System: General disorders
Frequency: 25 affected / 91 at risk

Adverse event: Irritability(post-Dose 2)
Serious: no
Organ System: General disorders
Frequency: 35 affected / 91 at risk

Adverse event: Loss of appetite (post-Dose 2)
Serious: no
Organ System: General disorders
Frequency: 22 affected / 91 at risk

Adverse event: Temperature (post-Dose 2)
Serious: no
Organ System: General disorders
Frequency: 18 affected / 91 at risk

Adverse event: Oral herpes
Serious: yes
Organ System: Infections and infestations
Frequency: 2 affected / 90 at risk

Adverse event: Gastroenteritis
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 90 at risk

Adverse event: Teratoma
Serious: yes
Organ System: Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Frequency: 1 affected / 90 at risk

Adverse event: Upper respiratory tract infection
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 90 at risk

Adverse event: Nasopharyngitis (post-Dose 1)
Serious: no
Organ System: Infections and infestations
Frequency: 18 affected / 90 at risk

Adverse event: Upper respiratory tract infection (post-Dose 1)
Serious: no
Organ System: Infections and infestations
Frequency: 9 affected / 90 at risk

Adverse event: Nasopharyngitis (post-Dose 2)
Serious: no
Organ System: Infections and infestations
Frequency: 7 affected / 90 at risk

Adverse event: Upper respiratory tract infection (post-Dose 2)
Serious: no
Organ System: Infections and infestations
Frequency: 5 affected / 90 at risk

Adverse event: Upper respiratory tract infection bacterial (post-Dose 2)
Serious: no
Organ System: Infections and infestations
Frequency: 5 affected / 90 at risk

Adverse event: Pain (post-Dose 1 of Synflorix)
Serious: no
Organ System: General disorders
Frequency: 47 affected / 88 at risk

Adverse event: Redness (post-Dose 1 of Synflorix)
Serious: no
Organ System: General disorders
Frequency: 32 affected / 88 at risk

Adverse event: Swelling (post-Dose 1 of Synflorix)
Serious: no
Organ System: General disorders
Frequency: 42 affected / 88 at risk

Adverse event: Pain (post-Dose 2 of Nimenrix)
Serious: no
Organ System: General disorders
Frequency: 34 affected / 85 at risk

Adverse event: Redness (post-Dose 2 of Nimenrix)
Serious: no
Organ System: General disorders
Frequency: 24 affected / 85 at risk

Adverse event: Swelling (post-Dose 2 of Nimenrix)
Serious: no
Organ System: General disorders
Frequency: 30 affected / 85 at risk

Adverse event: Drowsiness (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 35 affected / 88 at risk

Adverse event: Irritability (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 43 affected / 88 at risk

Adverse event: Loss of appetite (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 33 affected / 88 at risk

Adverse event: Temperature (post-Dose 1)
Serious: no
Organ System: General disorders
Frequency: 15 affected / 88 at risk

Adverse event: Drowsiness (post-Dose 2)
Serious: no
Organ System: General disorders
Frequency: 17 affected / 85 at risk

Adverse event: Irritability(post-Dose 2)
Serious: no
Organ System: General disorders
Frequency: 29 affected / 85 at risk

Adverse event: Loss of appetite (post-Dose 2)
Serious: no
Organ System: General disorders
Frequency: 22 affected / 85 at risk

Adverse event: Temperature (post-Dose 2)
Serious: no
Organ System: General disorders
Frequency: 11 affected / 85 at risk